Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
243.50    -5.00 (-2.01%)
Bid:
241.00
Ask:
245.50
Spread: 4.50 (1.867%)
Market Cap: £142.05m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jan 2015 07:00

RNS Number : 7095B
MJ Gleeson PLC
09 January 2015
 



MJ GLEESON PLC

('Gleeson' or 'the Group')

TRADING UPDATE

 

MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, today issues the following trading update ahead of its interim results for the six months ended 31 December 2014, which will be announced on Wednesday 25th February 2015.

 

The Group continues to trade well and expects profits for H1 2015 to show a strong increase over H1 2014.

 

Gleeson Homes

 

Market conditions remain healthy, with strong customer demand in all of our regions.

 

We continued to make strong progress in the period, selling 321 homes, an increase of 24% on the previous year's total of 258.

 

The current forward order book of 299 units is an increase of 23% over the previous year's figure of 240 and, as previously announced, the Board expects to record an increase in completions in the year to 30 June 2015 of not less than 25% against the prior year total of 561 units.

 

The business currently has 39 active sites, compared with 33 in the corresponding period.

 

The land pipeline of owned and conditionally purchased plots at 31 December 2014 increased by 30% compared to the prior year, totalling 5,267 plots, of which 1,588 plots have been purchased subject to planning permission. In addition, there are a further 1,900 plots which are in the pipeline to be acquired.

 

Gleeson Strategic Land

 

During the period we sold a 15 acre site with planning permission for 51 plots, along with the sale of 1.5 acres of commercial land from our site in Thanet, Kent.

 

There are currently eight sites in the portfolio with planning permission or a resolution to grant permission. Six of these sites, which will deliver 672 plots, are being progressed for sale in the current financial year.

 

In addition, there are 13 sites where the business is currently awaiting either the determination of a planning application or the outcome of a planning appeal. It may also be possible to sell a number of these sites in the current financial year.

 

Jolyon Harrison, Chief Executive, commented:

 

"The first half performance of both Gleeson Homes and Gleeson Strategic Land has been encouraging as we continue to benefit from our focussed, twin track strategy of providing low cost family homes in the North of England, and strategic land promotion in the South. We expect to report a result for the full year in line with current expectations."

 

9 January 2015

 

 

 

 

Enquiries:

 

MJ Gleeson plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Helen Tarbet

Mark Garraway

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

 

 

Notes to Editors

 

MJ Gleeson plc operates in the house building sector through the following business units: Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUMCGUPAGQR
Date   Source Headline
9th Apr 20134:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
6th Mar 20133:15 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSHalf Yearly Report
28th Feb 20137:00 amRNSTotal Voting Rights
6th Feb 20134:55 pmRNSDirector/PDMR Shareholding
31st Jan 20137:00 amRNSTotal Voting Rights
11th Jan 20137:00 amRNSTrading Statement
8th Jan 201311:03 amRNSDirector/PDMR Shareholding
31st Dec 20127:00 amRNSTotal Voting Rights
7th Dec 201212:02 pmRNSResult of AGM
7th Dec 201211:00 amRNSAGM Statement
6th Dec 20124:25 pmRNSDirector/PDMR Shareholding
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20129:15 amRNSHolding(s) in Company
7th Nov 20124:26 pmRNSPerformance Share Plan award to Director
5th Nov 20124:04 pmRNSDirector/PDMR Shareholding
31st Oct 20127:00 amRNSTotal Voting Rights
15th Oct 20122:15 pmRNSAdditional Listing
15th Oct 20121:57 pmRNSDirector/PDMR Shareholding
8th Oct 20122:40 pmRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSTotal Voting Rights
21st Sep 20127:00 amRNSFinal Results
7th Sep 20129:37 amRNSDirector/PDMR Shareholding
31st Aug 20127:00 amRNSTotal Voting Rights
7th Aug 20124:06 pmRNSDirector/PDMR Shareholding
31st Jul 20127:00 amRNSTotal Voting Rights
9th Jul 20127:00 amRNSDirector/PDMR Shareholding
4th Jul 20127:00 amRNSTrading Statement
2nd Jul 20127:00 amRNSDirectorate Change
29th Jun 20127:00 amRNSTotal Voting Rights
8th Jun 20123:10 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSTotal Voting Rights
11th May 20124:40 pmRNSSecond Price Monitoring Extn
11th May 20124:35 pmRNSPrice Monitoring Extension
11th May 20127:00 amRNSInterim Management Statement
10th May 201211:56 amRNSDirector/PDMR Shareholding
30th Apr 20127:00 amRNSTotal Voting Rights
13th Apr 20124:35 pmRNSPrice Monitoring Extension
11th Apr 201210:40 amRNSDirector/PDMR Shareholding
30th Mar 20127:00 amRNSTotal Voting Rights
7th Mar 20129:17 amRNSDirector/PDMR Shareholding
29th Feb 20121:42 pmRNSHolding(s) in Company
29th Feb 20127:00 amRNSTotal Voting Rights
27th Feb 201212:29 pmRNSHolding(s) in Company
22nd Feb 20127:00 amRNSHalf Yearly Report
15th Feb 20124:40 pmRNSSecond Price Monitoring Extn
15th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.